Re:Harvard and M.I.T. Scientists Win Gene-Editing Patent Fight
by refurb on Thursday February 16, 2017 @10:17AM
(#13660481)
Depending on what the other uses are, the patent holder is always able to out-license the patent for specific uses. This is actually pretty common in biotech.
Instead, we could grant subsidies and have multiple developments working in parallel.